{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:57:53Z","timestamp":1790503073194,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clim.2022.109031","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T04:25:31Z","timestamp":1651811131000},"page":"109031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["T cell dysregulation in SLE"],"prefix":"10.1016","volume":"239","author":[{"given":"Klaus","family":"Tenbrock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rauen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2019","key":"10.1016\/j.clim.2022.109031_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2022.109031_bb0010","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1084\/jem.20080840","article-title":"ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity","volume":"205","author":"Odegard","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109031_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000146","article-title":"Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus","volume":"3","author":"Sullivan","year":"2016","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.clim.2022.109031_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102668","article-title":"Phoenix from the flames: rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis","volume":"19","author":"Ramanujam","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2022.109031_bb0025","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.151.7.3914","article-title":"T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects","volume":"151","author":"Via","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0035","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0040","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109031_bb0045","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/1o6pn1","article-title":"Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus","author":"Miao","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2022.109031_bb0050","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2022.109031_bb0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2022.109031_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2022.109031_bb0065","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41551-021-00797-8","article-title":"Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells","volume":"5","author":"Zhang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.clim.2022.109031_bb0070","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/rheumatology\/kem154","article-title":"Altered signal transduction in SLE T cells","volume":"46","author":"Tenbrock","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2022.109031_bb0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2003.tb06054.x","article-title":"Activation of the Ets transcription factor Elf-1 requires phosphorylation and glycosylation: defective expression of activated Elf-1 is involved in the decreased TCR zeta chain gene expression in patients with systemic lupus erythematosus","volume":"987","author":"Tsokos","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109031_bb0080","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.4049\/jimmunol.169.10.6048","article-title":"Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus","volume":"169","author":"Juang","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0085","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4049\/jimmunol.168.6.2865","article-title":"Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain","volume":"168","author":"Juang","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0090","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.4049\/jimmunol.175.9.5975","article-title":"The cyclic AMP response element modulator regulates transcription of the TCR zeta-chain","volume":"175","author":"Tenbrock","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0095","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.4049\/jimmunol.166.6.4216","article-title":"Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus","volume":"166","author":"Solomou","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0100","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.4049\/jimmunol.169.8.4147","article-title":"Antisense cyclic adenosine 5\u2032-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus","volume":"169","author":"Tenbrock","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0105","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.4049\/jimmunol.170.6.2971","article-title":"The cyclic adenosine 5\u2032-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism","volume":"170","author":"Tenbrock","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0110","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.4049\/jimmunol.177.9.6159","article-title":"The transcriptional repressor cAMP response element modulator alpha interacts with histone deacetylase 1 to repress promoter activity","volume":"177","author":"Tenbrock","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0115","doi-asserted-by":"crossref","first-page":"43429","DOI":"10.1074\/jbc.M111.299339","article-title":"cAMP-responsive element modulator (CREM)\u03b1 protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus","volume":"286","author":"Hedrich","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0120","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1073\/pnas.1210129109","article-title":"cAMP response element modulator \u03b1 controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus","volume":"109","author":"Hedrich","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109031_bb0125","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1074\/jbc.M110.166785","article-title":"Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus","volume":"286","author":"Juang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0130","doi-asserted-by":"crossref","first-page":"32366","DOI":"10.1074\/jbc.M111.245811","article-title":"A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus","volume":"286","author":"Rauen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0135","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1073\/pnas.1807484116","article-title":"Phosphatase PP2A is essential for T(H)17 differentiation","volume":"116","author":"Xu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109031_bb0140","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.4049\/jimmunol.1200143","article-title":"Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism","volume":"188","author":"Crisp\u00edn","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0145","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.1073\/pnas.1103915108","article-title":"Induction of PP2A B\u03b2, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus","volume":"108","author":"Crisp\u00edn","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109031_bb0150","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1172\/JCI24895","article-title":"Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus","volume":"115","author":"Katsiari","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2022.109031_bb0155","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1172\/JCI22854","article-title":"Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV","volume":"115","author":"Juang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2022.109031_bb0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.30085","article-title":"Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium\/calmodulin-dependent protein kinase type IV","volume":"63","author":"Ichinose","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2022.109031_bb0165","doi-asserted-by":"crossref","first-page":"43437","DOI":"10.1074\/jbc.M111.299313","article-title":"cAMP-responsive element modulator (CREM)\u03b1 protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus","volume":"286","author":"Rauen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0170","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2022.109031_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2016.06.028","article-title":"CD95-mediated calcium signaling promotes T helper 17 trafficking to inflamed organs in lupus-prone mice","volume":"45","author":"Poissonnier","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2022.109031_bb0180","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.4049\/jimmunol.1900760","article-title":"cAMP response element modulator \u03b1 induces dual specificity protein phosphatase 4 to promote effector T cells in juvenile-onset lupus","volume":"203","author":"Hofmann","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0185","doi-asserted-by":"crossref","first-page":"12993","DOI":"10.1038\/ncomms12993","article-title":"ICER is requisite for Th17 differentiation","volume":"7","author":"Yoshida","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2022.109031_bb0190","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1074\/jbc.M111.323261","article-title":"cAMP-responsive element modulator \u03b1 (CREM\u03b1) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE)","volume":"287","author":"Hedrich","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0195","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crisp\u00edn","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jmcb\/mjs004","article-title":"CREM\u03b1 overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity","volume":"4","author":"Lippe","year":"2012","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.clim.2022.109031_bb0205","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2021-220687","article-title":"Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese","volume":"80","author":"Tomofuji","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2022.109031_bb0210","article-title":"Aberrant gut microbiome contributes to intestinal oxidative stress, barrier dysfunction, inflammation and systemic autoimmune responses in MRL\/lpr mice","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2220","article-title":"Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice","volume":"12","author":"Choi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2022.109031_bb0220","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1080\/19490976.2020.1768644","article-title":"Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus","volume":"11","author":"Guo","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.clim.2022.109031_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696074","article-title":"Lactobacillus acidophilus supplementation exerts a synergistic effect on tacrolimus efficacy by modulating Th17\/Treg balance in lupus-prone mice via the SIGNR3 pathway","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0230","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1073\/pnas.1714717115","article-title":"Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells","volume":"115","author":"Kono","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109031_bb0235","first-page":"1869","article-title":"Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis, arthritis","volume":"71","author":"Kono","year":"2019","journal-title":"Rheumatol"},{"key":"10.1016\/j.clim.2022.109031_bb0240","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fimmu.2019.00115","article-title":"Differential regulation of human Treg and Th17 cells by fatty acid synthesis and glycolysis","volume":"10","author":"Cluxton","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0250","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0255","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1073\/pnas.0807309106","article-title":"A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice","volume":"106","author":"Bubier","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109031_bb0260","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1084\/jem.183.5.2209","article-title":"CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions","volume":"183","author":"Oxenius","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109031_bb0265","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2005.10.017","article-title":"Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice","volume":"118","author":"Ding","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0270","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.M501459200","article-title":"Calcium-dependent activation of interleukin-21 gene expression in T cells","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jmcb\/mjs004","article-title":"CREMalpha overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity","volume":"4","author":"Lippe","year":"2012","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.clim.2022.109031_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cei.12629","article-title":"Interleukin-2 treatment reverses effects of cAMP-responsive element modulator alpha-over-expressing T cells in autoimmune-prone mice","volume":"181","author":"Ohl","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0285","first-page":"478","article-title":"Type I interferon-activated STAT4 regulation of follicular helper T cell-dependent cytokine and immunoglobulin production in lupus, arthritis","volume":"73","author":"Dong","year":"2021","journal-title":"Rheumatol"},{"key":"10.1016\/j.clim.2022.109031_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130062","article-title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","volume":"4","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.clim.2022.109031_bb0295","first-page":"150","article-title":"Effect of clonally expanded PD-1(high) CXCR5-CD4+ peripheral T helper cells on B cell differentiation in the joints of patients with antinuclear antibody-positive juvenile idiopathic arthritis, arthritis","volume":"74","author":"Fischer","year":"2022","journal-title":"Rheumatol"},{"key":"10.1016\/j.clim.2022.109031_bb0300","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0305","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-021-03692-z","article-title":"Metabolic control of T(FH) cells and humoral immunity by phosphatidylethanolamine","volume":"595","author":"Fu","year":"2021","journal-title":"Nature"},{"issue":"2021","key":"10.1016\/j.clim.2022.109031_bb0310","first-page":"269","article-title":"UPLC-MS\/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients","volume":"2","author":"Chen","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.clim.2022.109031_bb0315","first-page":"427","article-title":"Blockade of Treg cell differentiation and function by the Interleukin-21-mechanistic target of rapamycin Axis Via suppression of autophagy in patients with systemic lupus erythematosus, arthritis","volume":"70","author":"Kato","year":"2018","journal-title":"Rheumatol"},{"key":"10.1016\/j.clim.2022.109031_bb0320","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/ni.1917","article-title":"Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells","volume":"11","author":"Cardone","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0325","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Ip","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.clim.2022.109031_bb0330","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/096120339500400510","article-title":"Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity","volume":"4","author":"Houssiau","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2022.109031_bb0335","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1073\/pnas.1408023111","article-title":"Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling","volume":"111","author":"Hedrich","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109031_bb0340","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/1529-0131(200009)43:9<1976::AID-ANR8>3.0.CO;2-V","article-title":"Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients","volume":"43","author":"Lauwerys","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2022.109031_bb0345","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2019.09.031","article-title":"The YB-1:Notch-3 axis modulates immune cell responses and organ damage in systemic lupus erythematosus","volume":"97","author":"Breitkopf","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2022.109031_bb0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/embor.2009.81","article-title":"Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen","volume":"10","author":"Frye","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.clim.2022.109031_bb0355","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1073\/pnas.1917834117","article-title":"Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6(+)B helper T cells in systemic lupus erythematosus","volume":"117","author":"Facciotti","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109031_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009288","article-title":"Extrafollicular CD4 T cell-derived IL-10 functions rapidly and transiently to support anti-plasmodium humoral immunity","volume":"17","author":"Surette","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2022.109031_bb0365","doi-asserted-by":"crossref","first-page":"e01605","DOI":"10.1128\/mBio.01605-15","article-title":"DNA-containing Immunocomplexes promote Inflammasome assembly and release of pyrogenic cytokines by CD14+ CD16+ CD64high CD32low inflammatory monocytes from malaria patients","volume":"6","author":"Hirako","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.clim.2022.109031_bb0370","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0375","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0380","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaut.2010.06.018","article-title":"Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells","volume":"35","author":"Scheinecker","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2022.109031_bb0385","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.182.3.1689","article-title":"Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus","volume":"182","author":"Bonelli","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0390","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2007.074690","article-title":"Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis","volume":"67","author":"Bonelli","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2022.109031_bb0395","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1177\/0961203318804881","article-title":"Increased CD4(+)CD25(\u2212)Foxp3(+) T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement","volume":"27","author":"Yin","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2022.109031_bb0400","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2022.109031_bb0405","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.23556","article-title":"Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 \u2212\/low regulatory T cells in patients with active systemic lupus erythematosus","volume":"58","author":"Venigalla","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2022.109031_bb0410","first-page":"164","article-title":"Selective loss of signaling lymphocytic activation molecule family member 4-positive CD8+ T cells contributes to the decreased cytotoxic cell activity in systemic lupus erythematosus, arthritis","volume":"68","author":"Kis-Toth","year":"2016","journal-title":"Rheumatol"},{"key":"10.1016\/j.clim.2022.109031_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002328","article-title":"Exhausted cytotoxic control of Epstein-Barr virus in human lupus","volume":"7","author":"Larsen","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2022.109031_bb0420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cellimm.2005.06.010","article-title":"Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE","volume":"235","author":"Berner","year":"2005","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009858","article-title":"Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus","volume":"17","author":"Zhou","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2022.109031_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635531","article-title":"Double-edged sword: Interleukin-2 promotes T regulatory cell differentiation but also expands Interleukin-13- and interferon-\u03b3-producing CD8(+) T cells via STAT6-GATA-3 Axis in systemic lupus erythematosus","volume":"12","author":"Kato","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0435","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1172\/JCI120859","article-title":"Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted","volume":"128","author":"Tilstra","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2022.109031_bb0440","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1074\/jbc.M113.523605","article-title":"Tsokos, cAMP responsive element modulator (CREM) \u03b1 mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells","volume":"289","author":"Hedrich","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0445","doi-asserted-by":"crossref","first-page":"31880","DOI":"10.1074\/jbc.M113.508655","article-title":"cAMP-responsive element modulator \u03b1 (CREM\u03b1) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease","volume":"288","author":"Hedrich","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2022.109031_bb0450","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/s41467-020-16636-4","article-title":"Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2022.109031_bb0455","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1172\/JCI81059","article-title":"Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus","volume":"125","author":"Li","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2022.109031_bb0460","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.1300041","article-title":"Cutting edge: defective follicular exclusion of apoptotic antigens due to marginal zone macrophage defects in autoimmune BXD2 mice","volume":"190","author":"Li","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0465","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2022.109031_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688753","article-title":"Comparison of surrogate markers of the type I interferon response and their ability to Mirror disease activity in systemic lupus erythematosus","volume":"12","author":"Enocsson","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0475","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13075-021-02414-0","article-title":"The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus","volume":"23","author":"Mai","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2022.109031_bb0480","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-020-02177-0","article-title":"The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis","volume":"22","author":"Wilkinson","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2022.109031_bb0485","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0961203320965690","article-title":"Associations of site-specific CD4(+)-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus","volume":"30","author":"Vordenb\u00e4umen","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2022.109031_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.848149","article-title":"Identification and contribution of inflammation-induced novel MicroRNA in the pathogenesis of systemic lupus erythematosus","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0495","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13223-017-0188-7","article-title":"Elevated expression of TIGIT on CD3(+)CD4(+) T cells correlates with disease activity in systemic lupus erythematosus","volume":"13","author":"Luo","year":"2017","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.clim.2022.109031_bb0500","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2018.11.008","article-title":"BAFF-R and TACI expression on CD3+ T cells: interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus","volume":"114","author":"Salazar-Camarena","year":"2019","journal-title":"Cytokine"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:06:56Z","timestamp":1761494816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":100,"alternative-id":["S1521661622001127"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109031","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell dysregulation in SLE","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109031"}}